CYTOF — Altamira Therapeutics Ltd.
—
OTC ·
Health Care ·
Pharmaceuticals ·
CIK 1601936 ·
Last close
$0.07
Market Cap
$411.5K
52W High
$0.15
52W Low
$0.05
ADV30
4,433
Next earnings
2026-09-30
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2025 | — | — | — | — | 7,130,183 | 3,755 | 3,056,371 |
| Dec 2024 | — | — | — | — | 8,652,136 | 998,624 | 2,087,030 |
Balance + Analyst (yfinance extras)
Retained Earnings
$-4,041,241
Inventory
$0
Receivables
$213,389
ST Investments
—
EBIT TTM
—
Pretax Income TTM
—
Interest Exp TTM
—
Analysts
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2024 | 0 | -6,921,740 | -8,457,748 | 8,652,136 | 2,087,030 | 6,565,106 | -6,113,547 |
| Dec 2023 | 0 | -6,601,112 | -4,306,260 | 9,143,504 | 1,468,261 | 7,675,243 | -12,811,427 |
| Dec 2022 | 0 | -18,862,743 | -27,778,443 | 6,813,063 | 15,801,076 | -8,988,013 | -9,092,388 |
| Dec 2021 | 0 | -7,517,066 | -18,661,463 | 20,971,798 | 6,710,502 | 14,261,296 | -14,957,595 |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| RGBPP | Regen BioPharma Inc | $460.3K | $0.00 | — |
| BDRX | Biodexa Pharmaceuticals Plc | $695.6K | $0.68 | — |
| ZVSA | ZyVersa Therapeutics, Inc. | $801.5K | $0.10 | — |
| OCEA | Ocean Biomedical, Inc. | $185.9K | $0.00 | — |
| PTPI | Petros Pharmaceuticals, Inc. | $169.5K | $0.00 | — |
News headlines (Yahoo Finance, 1h cache)
Altamira Therapeutics Provides Business Update and Reports Full Year 2025 Financial Results
2026-03-31 13:00 · Yahoo
Altamira Therapeutics Announces Publication Highlighting Potential of RNA Nanoparticles for Disease-Modifying Treatment of Osteoarthritis
2026-04-13 13:00 · Yahoo
Altamira Therapeutics Announces Release Date for 2025 Annual Report and Financial Statements
2026-03-24 13:00 · Yahoo
Altamira Therapeutics Announces Allowance of Japanese Patent Application Covering Bentrio Nasal Spray
2026-02-13 14:00 · Yahoo
Altamira Therapeutics Announces Market Approval of Bentrio Nasal Spray in China
2025-12-19 14:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.